Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats

[1]  E. Bullmore,et al.  The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. , 2012, The international journal of neuropsychopharmacology.

[2]  L. Cervo,et al.  Bifeprunox: a partial agonist at dopamine D2 and serotonin1A receptors, influences nicotine‐seeking behaviour in response to drug‐associated stimuli in rats , 2012, Addiction biology.

[3]  B. Kiss,et al.  Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents , 2011, Neurochemistry International.

[4]  L. Schmidt,et al.  The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study Dual diagnosis over 15 years , 2011, Schizophrenia Research.

[5]  A. Pesce,et al.  Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self‐administration , 2011, Synapse.

[6]  A. Benyamina,et al.  Pharmacological treatments for cocaine dependence: is there something new? , 2011, Current pharmaceutical design.

[7]  M. Haney,et al.  Aripiprazole maintenance increases smoked cocaine self-administration in humans , 2011, Psychopharmacology.

[8]  G. Németh,et al.  The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia , 2011, European Psychiatry.

[9]  N. S. Pentkowski,et al.  Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior , 2010, Behavioural Brain Research.

[10]  I. Laszlovszky,et al.  P.3.c.062 The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia , 2010, European Neuropsychopharmacology.

[11]  John Suckling,et al.  Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. , 2010, Archives of general psychiatry.

[12]  Eva Schmidt,et al.  Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile , 2010, Journal of Pharmacology and Experimental Therapeutics.

[13]  R. See,et al.  Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse , 2009, Psychopharmacology.

[14]  I. Laszlovszky,et al.  P.2.e.037 The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial , 2009, European Neuropsychopharmacology.

[15]  C. Bétry,et al.  Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation , 2009, Neuroscience Letters.

[16]  Sylvia M. L. Cox,et al.  Striatal Dopamine Responses to Intranasal Cocaine Self-Administration in Humans , 2009, Biological Psychiatry.

[17]  M. Millan,et al.  The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats , 2009, Neuropharmacology.

[18]  R. Spealman,et al.  Controversies in translational research: drug self-administration , 2008, Psychopharmacology.

[19]  J. Swanson,et al.  Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. , 2007, Archives of neurology.

[20]  Z. Xi,et al.  Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. , 2007, CNS drug reviews.

[21]  K. Berridge.  The debate over dopamine’s role in reward: the case for incentive salience , 2007, Psychopharmacology.

[22]  C. Altar,et al.  Aripiprazole Blocks Reinstatement of Cocaine Seeking in an Animal Model of Relapse , 2007, Biological Psychiatry.

[23]  B. Kiss,et al.  Effects of RGH-237 [N-{4-[4-(3-Aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an Orally Active, Selective Dopamine D3 Receptor Partial Agonist in Animal Models of Cocaine Abuse , 2007, Journal of Pharmacology and Experimental Therapeutics.

[24]  I. Gyertyán,et al.  Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats. , 2006, Drug and alcohol dependence.

[25]  D. Karanian,et al.  Effects of intranucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat , 2005, Psychopharmacology.

[26]  P. Sokoloff,et al.  The dopamine D3 receptor and drug dependence: Effects on reward or beyond? , 2005, Neuropharmacology.

[27]  Henry F. Beresford,et al.  Aripiprazole in Schizophrenia With Cocaine Dependence: A Pilot Study , 2005, Journal of clinical psychopharmacology.

[28]  Z. Xi,et al.  Acute administration of SB‐277011A, NGB 2904, or BP 897 inhibits cocaine cue‐induced reinstatement of drug‐seeking behavior in rats: Role of dopamine D3 receptors , 2005, Synapse.

[29]  A. Barrett,et al.  Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats , 2004, Neuropharmacology.

[30]  J. Swanson,et al.  Dopamine in drug abuse and addiction: results from imaging studies and treatment implications , 2004, Molecular Psychiatry.

[31]  I. Gyertyán,et al.  Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats , 2003, Brain Research Bulletin.

[32]  M. Cador,et al.  Differential effects of dopaminergic agents on locomotor sensitisation and on the reinstatement of cocaine-seeking and food-seeking behaviour , 2003, Psychopharmacology.

[33]  L. Cervo,et al.  Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D3 and D2 Dopamine Receptors* , 2003, Neuropsychopharmacology.

[34]  B. Everitt,et al.  Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A , 2003, Neuropsychopharmacology.

[35]  Y. Shaham,et al.  Effect of Dopamine Receptor Antagonists on Renewal of Cocaine Seeking by Reexposure to Drug-associated Contextual Cues , 2002, Neuropsychopharmacology.

[36]  R. Spealman,et al.  Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. , 2000, The Journal of pharmacology and experimental therapeutics.

[37]  C. Bradberry,et al.  Impact of Self-Administered Cocaine and Cocaine Cues on Extracellular Dopamine in Mesolimbic and Sensorimotor Striatum in Rhesus Monkeys , 2000, The Journal of Neuroscience.

[38]  J. Stewart,et al.  Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. , 2000, Journal of psychiatry & neuroscience : JPN.

[39]  L. Baker,et al.  Analysis of D2 and D3 Receptor-Selective Ligands in Rats Trained to Discriminate Cocaine from Saline , 1999, Pharmacology Biochemistry and Behavior.

[40]  G. Koob,et al.  Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. , 1998, The Journal of pharmacology and experimental therapeutics.

[41]  Y. Hurd,et al.  In vivo Amygdala Dopamine Levels Modulate Cocaine Self‐administration Behaviour in the Rat: D1 Dopamine Receptor Involvement , 1997, The European journal of neuroscience.

[42]  B. Everitt,et al.  D3 receptor test in vitro predicts decreased cocaine self‐administration in rats , 1997, Neuroreport.

[43]  M. Nader,et al.  Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline , 1996, Psychopharmacology.

[44]  S. B. Caine,et al.  Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat , 1995, Brain Research.

[45]  H. Wikström,et al.  Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. , 1995, European journal of pharmacology.

[46]  D. Hoffman,et al.  Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability , 1995, Psychopharmacology.

[47]  G. F. Koob,et al.  Pretreatment with the dopamine agonist 7‐OH‐DPAT shifts the cocaine self‐administration dose‐effect function to the left under different schedules in the rat , 1995, Behavioural pharmacology.

[48]  R. Ehrman,et al.  Classical Conditioning in Drug‐Dependent Humans a , 1992, Annals of the New York Academy of Sciences.

[49]  W. Corrigall,et al.  Cocaine self-administration is increased by both D1 and D2 dopamine antagonists , 1991, Pharmacology Biochemistry and Behavior.

[50]  J. Stewart,et al.  Reinstatement of cocaine-reinforced responding in the rat , 2004, Psychopharmacology.

[51]  R. Drake,et al.  Psychosocial approaches to dual diagnosis. , 2000, Schizophrenia bulletin.

[52]  B. Pitt.  Psychopharmacology , 1968, Mental Health.